Health and Biotechnologies Challenge

Biotechnologies are a collection of techniques, methods and processes using biological systems to develop new products, processes and/or services that can be used in many sectors, particularly in health, the food industry and for the environment. In the health sector, the development of new products which are more specific and more efficient, the perfection of new therapies and medical diagnostics rely more and more on biotechnologies.

Biotechnologies are thus a vehicle for major cultural and social changes; changes in methods of treatment, changes in methods of agricultural and industrial production, in the concept of protecting our environment and the evolution of food. These changes have a major impact on our habits, our behaviour and our life. They also generally raise questions about ethics.

For example, in the field of health, there is still a vast area where the diversity of potential action remains to be explored. The economic considerations are simple – the growth of the health budget is faster than that of the activity which generates the means to meet it. The French health budget represents approximately two-thirds of the State budget. It is therefore a key sector and engineers need to be able to bring to it the skills in procedures and networks that they have already acquired in industry and services.

Associated laboratories

  • Chemical Engineering Laboratory (LGPM) - EA 4038
    Within this framework, the School has created a centre of excellence in industrial Biotechnologies, based in Châtenay-Malabry and Reims.
  • Applied Mathematics and Systems Laboratory (MAS) - EA 4037
  • Industrial Engineering Laboratory (LGI) - EA 2606
  • Physical Properties of Materials and Modelling Laboratory (SPMS) - CNRS-UMR 8580

Options, courses, Advanced Masters and Masters

Engineering course:


Two options in the 3rd year specifically include biotechnologies. They are:

  • Environment, Materials and Life Science (OEV)
  • Applied Mathematics option (OMA)

The Applied Physics and Energy options also introduce these themes.



Master:


Biology and biotechnologies are more specifically raised in two of the Ecole Centrale Paris’ Masters degrees:

  • Field of Applied Mathematics and Information Sciences (MASI), M2 Systematic and Synthetic Biology (BSS)
  • Field of Applied Sciences, M2 Processes, Environment and Biotechnology

Advanced Masters:

The School offers 3 Advanced Masters in the field of health:

  • Risk and Safety Management in health establishments and networks;
  • Information and Knowledge Engineering of health care institutions;
  • Management and Technology of health care institutions and networks.

Courses

Common track

  • PR5100: Biology

Electives

  • PR2100: Water treatment and underground water protection - elective S8
  • PR310: Design of industrial procedures for energy, the environment and biotechnologies 1 – electives S6, S8
  • PR3300: Design of industrial procedures for energy, the environment and biotechnologies 2 - elective S8
  • PR3910: Experimental module l – Biotechnology – elective S8
  • PR5110: Life sciences and biotechnology – electives S6, S8
  • PR5200: Life sciences: biophysics, cellular and molecular biology – elective S7
  • PR5300: Physiology and biotechnology – elective S7
  • PR5950: Cellular and molecular biology laboratory -  elective S8

Experimental activity

  • PR 2940: Chemical and Environmental Engineering Laboratory

Conferences

The “Challenge” conference programme for the year 2010 – 2011 covered the following subjects:

  • Introductory conference: “Health in France”, Thierry Dieuleveux, General Secretary, inter-ministerial mission for disability
  • Medico-economic evaluations of preventive actions in the field of health (B. Dervaux, - Lille University 2 "Law and Health");
  • Imaging in the medical field (Nicholas Ayache, INRIA)
  • Biocarburants (Xavier Montagne, IFP)
  • The laws of bioethics (C. Huriet, Director, Curie Institute);
  • Bioproduction, health care biotechnologies (Françoise Russo-Marie, Génopole)
  • Presentation of the hospital and its reforms (B. Bonan, Head of Pharmaceutical Service, Hôpital Foch, Suresnes)
  • The economy of health (Gérard de Pouvourville, ESSEC)
  • Elements of epidemiology (D. Guillemot, Pasteur Institute)

Companies incubated at Centrale Paris

  • NanoE is specialised in the elaboration of very high quality ultrafine nanopowders,
  • Emulsar creates nanoemulsions which allow more efficient medicines to be manufactured,
  • Cryolog markets freshness labels on a wide scale,
  • Voluntis offers a medical software programme used by nearly 500 000 patients.
  • rss

Filipa LOPES

Coordinator Email : filipa.lopes@ecp.fr

Véronique LETORT

Deputy Coordinator Email : veronique.letort@ecp.fr